Unlike K562 (a blast crisis CML cell line), we observed that the level of BCR-ABL protein was low in the fractions 11, 12, and 13 of the patient's sample (Figure 1A). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.